Modern Dental Group Announces 2026 Interim Results 
Merdeka Gold Delivers Strong Q2 Production Ramp-Up as Pani Gold Mine Advances Toward Full-year Growth 
Nissin Foods Announces 2026 Interim Results 
The World’s Leading Minds in Biotechnology Will Meet in Riyadh This September 
Overseas Growth Gathers Momentum as CanSinoBIO’s Global Strategy Unlocks New Opportunities Box and CrowdStrike Partner to Combat Cyber Threats and Secure Content in the Cloud
New Partnership Delivers First-Of-Its-Kind Security Capabilities To Joint Customers Of All Sizes REDWOOD CITY, Calif….
TG Therapeutics Announces Presentation of Data for BRIUMVI at the 2023 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting
NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the…
MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab for Hidradenitis Suppurativa at the European Academy of Dermatology and Venereology Congress
MoonLake Immunotherapeutics presents positive 12-week data from the Phase 2 MIRA trial with Nanobody® Sonelokimab…
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) — Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), a biotechnology…
Anaptys to Present Phase 1 Data on ANB032, its BTLA Agonist Antibody, at the 32nd EADV Congress
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology…
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
TEL AVIV, ISRAEL, Oct. 11, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc” or…
Balancing risk and rewards of AI the key agenda of tech leaders at Tech Week Singapore
Singapore, Oct 11, 2023 – (ACN Newswire) – Artificial intelligence (AI) has experienced a breakout…
Arista 7130 Series Leads the Way to 25G Ultra-Low Latency Networking
Driving customer value through innovation SANTA CLARA, Calif.–(BUSINESS WIRE)–Arista Networks (NYSE:ANET) today announced the next…
Acxiom Recognized as A Leader in Snowflake’s Modern Marketing Data Stack Report
Acxiom enables joint customers to build leading solutions on Snowflake’s Data Cloud that unlocks valuable…
C3 AI and Shell Expand Collaboration for Asset Monitoring and Predictive Maintenance
C3 AI Reliability to include the AI models and specific features developed by Shell Global…
CentralSquare Partners with RapidSOS to Enhance School Safety by Providing Immediate Emergency Detection and Situational Awareness for Faster Response
RapidSOS will integrate seamlessly into CentralSquare’s Computer Aided Dispatch (CAD) to introduce multimedia services, including…
Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
Palisade Bio to Participate at the Virtual Investor Ask the CEO Conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October…
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conference
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday,…
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
Data Demonstrating Financial Impact of INPEFA® (Sotagliflozin) to be Presented at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023 National Meeting
Studies address cost-effectiveness and budget impact of INPEFA, an inhibitor of SGLT2 and SGLT1 INPEFA recently…
Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Revive Therapeutics Provides Update of Novel Bucillamine Formulation Development
TORONTO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Yield10 Bioscience Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina
-On track for commercial launch of first herbicide tolerant Camelina variety as early as 2025…